Literature DB >> 13162833

Studies in myasthenia gravis; preliminary report on therapy with mestinon bromide.

K E OSSERMAN, P TENG, L I KAPLAN.   

Abstract

Entities:  

Keywords:  MYASTHENIA GRAVIS/therapy; PARASYMPATHOMIMETICS/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13162833     DOI： 10.1001/jama.1954.03690290011004

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  6 in total

1.  [Not Available].

Authors:  K E OSSERMAN
Journal:  Klin Wochenschr       Date:  1959-01-01

Review 2.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

Review 3.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

4.  Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study.

Authors:  Sergio I Valdés-Ferrer; José C Crispín; Pablo F Belaunzarán-Zamudio; Carlos A Rodríguez-Osorio; Bernardo Cacho-Díaz; Jorge Alcocer-Varela; Carlos Cantú-Brito; Juan Sierra-Madero
Journal:  Front Immunol       Date:  2017-10-18       Impact factor: 7.561

Review 5.  A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature.

Authors:  Maria Elena Farrugia; John A Goodfellow
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 6.  Current Treatment of Myasthenia Gravis.

Authors:  Mohammed K Alhaidar; Sumayyah Abumurad; Betty Soliven; Kourosh Rezania
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.